Inactive Instrument

Press Releases Venn Life Sciences Holdings London S.E.

Equities

HVIVO : Interim Results 2023	23-09-12	PU
HVIVO : Trading Update H1 2023	23-07-26	PU
HVIVO : 2023 AGM Notice & Proxy Form	23-04-28	PU
HVIVO hails growing contract values after winning £13.6mln RSV challenge trial deal	22-11-14	EQ
Open Orphan : Interim Results Presentation September 2022	22-09-09	PU
Open Orphan : 2022 AGM Form of Proxy	22-06-10	PU
Open Orphan : 2022 AGM Notice	22-06-10	PU
Open Orphan : Annual Report 2021	22-06-08	PU
Open Orphan : Investors Presentation June 2022	22-06-08	PU
AIM ImmunoTech : Announces Phase 2a Human Challenge Trial to Test its Drug Ampligen as an Intranasal Antiviral Prophylactic Therapy	21-07-12	AQ
AIM ImmunoTech : Announces Phase 2a Human Challenge Trial to Test its Drug Ampligen as an Intranasal Antiviral Prophylactic Therapy	21-07-09	AQ
Open Orphan : Publication of positive results in journal ● ●	20-03-16	PU
Open Orphan : Publication of positive results in journal	20-03-16	PU
Open Orphan : Holding(s) in Company ●	20-03-12	PU
Open Orphan : Publication of Positive Results in Journal ●	20-03-10	PU
Open Orphan : Completion of Compulsory Acquisition of Shares ● ●	20-03-09	PU
Open Orphan : Completion of Compulsory Acquisition of Shares	20-03-09	PU
Open Orphan : Coronavirus Challenge Study Model	20-03-09	PU
Open Orphan : New Contract ● ●	20-03-06	PU
Open Orphan : New Contract	20-03-06	PU

No results for this search